Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysis

Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysis

Introduction: High-dose trivalent, inactivated, split-virus influenza vaccine (IIV3-HD) has been available in the US since 2009 for adults aged ≥ 65 years. To better understand how IIV3-HD provides improved protection against influenza, we systematically reviewed clinical studies comparing immune re...

Full description

Bibliographic Details
Main Authors: Sandrine I. Samson, Phillip S. Leventhal, Camille Salamand, Ya Meng, Bruce T. Seet, Victoria Landolfi, David Greenberg, Rosalind Hollingsworth
Format: Article
Language:English
Published: Taylor & Francis Group 2019-03-01
Series:Expert Review of Vaccines
Subjects:
elderly adults
high-dose influenza vaccine
immunocompromised
immunogenicity
systematic review
Online Access:http://dx.doi.org/10.1080/14760584.2019.1575734

Internet

http://dx.doi.org/10.1080/14760584.2019.1575734

Similar Items